Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Virpax Pharmaceuticals Inc (VRPX)

Virpax Pharmaceuticals Inc (VRPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Virpax Pharmaceuticals Inc 1055 Westlakes Drive Suite 300 Berwyn PA 19312 USA

www.virpaxpharma.com Employees: 7 P: 610-727-4597

Description:

Virpax Pharmaceuticals Inc. is a preclinical stage biopharmaceutical company. It is focused on pain management by developing and delivering non-opioid and non-addictive pharmaceutical products using new drug delivery systems and technology. Virpax Pharmaceuticals Inc. is based in WEST CHESTER, PA.

Key Statistics

Overview:

Market Capitalization, $K 3,002
Enterprise Value, $K -6,138
Shares Outstanding, K 4,888
Annual Sales, $ 0 K
Annual Net Income, $ -15,190 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,450 K
EBIT, $ -17,560 K
EBITDA, $ -17,560 K
60-Month Beta 1.09
% of Insider Shareholders 4.20%
% of Institutional Shareholders 32.23%
Float, K 4,682
% Float 95.80%
Short Volume Ratio 0.26

Growth:

1-Year Return -91.72%
3-Year Return -98.52%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.75 on 08/12/24
Next Earnings Date 11/20/24 [--]
Earnings Per Share ttm -9.60
EPS Growth vs. Prev Qtr 75.43%
EPS Growth vs. Prev Year 91.57%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 03/01/24

VRPX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -1,554.34%
Return-on-Assets % -258.74%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.98
Interest Coverage -0.44
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar